Literature DB >> 2541162

Impaired late suppression of Epstein-Barr virus (EBV)-induced immunoglobulin synthesis: a common feature of autoimmune disease.

A Shore1, R Klock, P Lee, K M Snow, E C Keystone.   

Abstract

We examined regulation of Epstein-Barr virus-induced plaque-forming cell generation in peripheral blood mononuclear cells from several autoimmune and seronegative diseases and correlated these results with Epstein-Barr virus-induced proliferation. We confirmed the defective regulation of Epstein-Barr virus-induced plaque-forming cells in peripheral blood mononuclear cells of patients with rheumatoid arthritis and scleroderma. Peripheral blood mononuclear cells from patients with seronegative arthropathies and chronic infective inflammation (cystic fibrosis) had normal regulation of Epstein-Barr virus-induced plaque-forming cells. Peripheral blood mononuclear cells from rheumatoid arthritis had excessive plaque-forming cell generation in the face of a normally regulated decrease in Epstein-Barr virus-induced proliferation. In contrast, peripheral blood mononuclear cells from scleroderma had defective suppression of both Epstein-Barr virus-induced proliferation and plaque-forming cell generation. Thus, impaired regulation of Epstein-Barr virus-induced plaque-forming cell generation is a common feature of autoimmune disease and demonstrates some specificity for these disorders.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2541162     DOI: 10.1007/bf00916937

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  15 in total

1.  Thymosin induces helper function in OKT3-positive, E-rosette-negative human cord blood T cells.

Authors:  P L Tan; A Shore
Journal:  Scand J Immunol       Date:  1984-07       Impact factor: 3.487

2.  T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals.

Authors:  G Tosato; I T Magrath; R M Blaese
Journal:  J Immunol       Date:  1982-02       Impact factor: 5.422

3.  Spontaneous reverse haemolytic plaque formation. I. Technical aspects of the protein A assay.

Authors:  G F Burns; B L Pike
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

4.  Defective Epstein-Barr virus specific suppressor T cell function in progressive systemic sclerosis.

Authors:  A Kahan; A Kahan; C J Menkes; B Amor
Journal:  Ann Rheum Dis       Date:  1986-07       Impact factor: 19.103

5.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

6.  Immunoglobulin production in vitro by peripheral blood lymphocytes in systemic lupus erythematosus: helper T cell defect and B cell hyperreactivity.

Authors:  P Tan; G Pang; J D Wilson
Journal:  Clin Exp Immunol       Date:  1981-06       Impact factor: 4.330

7.  Immunoglobulin-secreting cells in SLE: correlation with disease activity.

Authors:  P L Tan; G T Pang; G Cullinane; J D Wilson
Journal:  J Rheumatol       Date:  1980 Nov-Dec       Impact factor: 4.666

8.  Impaired regulation of Epstein-Barr virus-induced lymphocyte proliferation in rheumatoid arthritis is due to a T cell defect.

Authors:  J M Depper; H G Bluestein; N J Zvaifler
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

9.  Epstein-Barr virus induces normal B cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus.

Authors:  G C Tsokos; I T Magrath; J E Balow
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

10.  Analysis of the defects responsible for the impaired regulation of Epstein-Barr virus-induced B cell proliferation by rheumatoid arthritis lymphocytes. I. Diminished gamma interferon production in response to autologous stimulation.

Authors:  F Hasler; H G Bluestein; N J Zvaifler; L B Epstein
Journal:  J Exp Med       Date:  1983-01-01       Impact factor: 14.307

View more
  4 in total

Review 1.  The Epstein-Barr virus in autoimmunity.

Authors:  J H Vaughan
Journal:  Springer Semin Immunopathol       Date:  1995

Review 2.  Fresh Insights into Disease Etiology and the Role of Microbial Pathogens.

Authors:  Antonella Farina; G Alessandra Farina
Journal:  Curr Rheumatol Rep       Date:  2016-01       Impact factor: 4.592

3.  Epstein-Barr virus-induced autoimmune responses. II. Immunoglobulin G autoantibodies to mimicking and nonmimicking epitopes. Presence in autoimmune disease.

Authors:  J H Vaughan; M D Nguyen; J R Valbracht; K Patrick; G H Rhodes
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

4.  CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis.

Authors:  Michael P Pender
Journal:  Autoimmune Dis       Date:  2012-01-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.